BioGraph 55

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttp://biograph55.com/

Last Round

Series B

Jun 1, 2024

Total Funding Raised

$20.1M

Company Overview

BioGraph 55 is a drug discovery company that develops novel B-cell therapies and drugs for autoimmunity and immuno-oncology using a proprietary spatial 'omics' platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

spatial biologydrug discoveryspatial omicstarget identificationimmuno-oncologybispecific antibodiesIOautoimmune disease therapybiotechtherapeutic developmentB-cell therapiesdrug discovery platformbiologics developmenttissue analysispreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioGraph 55 Comps

Public and private peers based on sector, stage, and business model.

BioGraph 55 comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioGraph 55 Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jun 1, 2024
Series A	Mar 1, 2023

View all Funding Rounds

BioGraph 55 Investors

Notable investors and investment history

BioGraph 55 investors
Investor	Rounds
Pathway Bioventures	Series B, Series A
Red Tree Venture Capital	Series B, Series A
Pfizer Ventures	Series B, Series A

View all Investors

BioGraph 55 Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BioGraph 55 Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioGraph 55's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range4

Year Founded2014

Last FundingJun 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.